Proceedings of the National Academy of Sciences · 1997 · 416 citations · 21 references
Life SciencesInfectious DiseasesMolecular BiologyMolecular VirologyVaccinologyVirologyViral AttachmentViral GeneticsViral InfectionsViral ReplicationViral Rna BiologyViral VaccinesNegative-sense Rna Virus ReplicationRespiratory Syncytial Virus VaccinesReverse Transcription Polymerase Chain Reaction (Rt-pcr)Viral Attachment ProteinsViral Envelope GlycoproteinsViral Envelope ProteinsViral GlycoproteinsViral Surface Proteins
A live, cold-passaged (cp) candidate vaccine virus, designated respiratory syncytial virus (RSV) B1 cp-52/2B5 (cp-52), replicated efficiently in Vero cells, but was found to be overattenuated for RSV-seronegative infants and children. Sequence analysis of reverse-transcription-PCR-amplified fragments of this mutant revealed a large deletion spanning most of the coding sequences for the small hydrophobic (SH) and attachment (G) proteins. Northern blot analysis of cp-52 detected multiple unique read-through mRNAs containing SH and G sequences, consistent with a deletion mutation spanning the SH:G gene junction. Immunological studies confirmed that an intact G glycoprotein was not produced by the cp-52 virus. Nonetheless, cp-52 was infectious and replicated to high titer in tissue culture despite the absence of the viral surface SH and G glycoproteins. Thus, our characterization of this negative-strand RNA virus identified a novel replication-competent deletion mutant lacking two of its three surface glycoproteins. The requirement of SH and G for efficient replication in vivo suggests that selective deletion of one or both of these RSV genes may provide an alternative or additive strategy for developing an optimally attenuated vaccine candidate.
21
Peter L. Collins, M G Hill, Ena Camargo et al. · Proceedings of the National Academy of Sciences · 1995 · 447 citations
Charles B. Hall, Edward E. Walsh, Kenneth C. Schnabel et al. · The Journal of Infectious Diseases · 1990 · 350 citations
Brian R. Murphy, Alex V. Sotnikov, Lisa Lawrence et al. · Vaccine · 1990 · 272 citations
Mark Connors, Arun B. Kulkarni, Cai-Yen Firestone et al. · Journal of Virology · 1992 · 267 citations · Full text
Ruth A. Karron, Peter F. Wright, James E. Crowe et al. · The Journal of Infectious Diseases · 1997 · 207 citations · Full text